Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolonged Emesis Causing Esophageal Perforation: A Case Report.

Cureus·2022
Same author

Severe Post-prandial Pain: A Case Report.

Cureus·2022
Same author

Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses.

AJR. American journal of roentgenology·2008
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 20, 2025

Robotic Spleen-Preserving Distal Pancreatectomy: The Warshaw and Kimura Techniques
07:33

Robotic Spleen-Preserving Distal Pancreatectomy: The Warshaw and Kimura Techniques

Published on: July 26, 2024

2.1K

Accessory Spleen Masquerading as an Intrapancreatic Tumor: A Case Report.

Harrison C Smith1, Nandita Kakar1, Anthony M Shadid2

  • 1Medical School, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.

Cureus
|June 6, 2022
PubMed
Summary

Splenosis or intrapancreatic accessory spleen (IPAS) can mimic pancreatic cancer. Non-invasive imaging like CT and MRI, confirmed by nuclear medicine, helps differentiate this benign condition, avoiding unnecessary procedures.

Keywords:
abdominal painaccessory spleenectopic spleennuclear medicine imagingpancreatic tumorsplenosis

More Related Videos

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.1K
Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma
03:55

Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma

Published on: December 29, 2023

646

Related Experiment Videos

Last Updated: Sep 20, 2025

Robotic Spleen-Preserving Distal Pancreatectomy: The Warshaw and Kimura Techniques
07:33

Robotic Spleen-Preserving Distal Pancreatectomy: The Warshaw and Kimura Techniques

Published on: July 26, 2024

2.1K
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.1K
Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma
03:55

Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma

Published on: December 29, 2023

646

Area of Science:

  • Gastroenterology
  • Radiology
  • Nuclear Medicine

Background:

  • Splenic tissue in the pancreas (splenosis or intrapancreatic accessory spleen - IPAS) is uncommon.
  • It often presents as an intrapancreatic mass, raising concern for malignancy.

Observation:

  • Intrapancreatic masses frequently trigger extensive diagnostic workups for pancreatic cancer.
  • This can lead to unnecessary invasive tests and surgeries for benign conditions like IPAS.

Findings:

  • Contrast-enhanced CT and MRI show similar signal intensities and enhancement patterns between the spleen and IPAS.
  • Tc-99m heat-damaged red blood cell (HDRBC) nuclear medicine scans confirm IPAS by demonstrating uptake.

Implications:

  • Non-invasive diagnostic techniques are crucial for correctly identifying IPAS.
  • Accurate diagnosis reduces patient exposure to risks associated with invasive procedures and surgery.
  • Differentiating IPAS from pancreatic malignancy improves patient outcomes and healthcare resource allocation.